Thus, prominent myocardial hypertrophy and diastolic dysfunction showed a dependency on Ang II dose, but not hypertension, suggesting that Ang II is mediating LV fibrosis and cardiomyocyte hypertrophy via its other mechanisms such as the regulation of inflammation and cell proliferation. This evidence concerns the gene AGT and cardiac hypertrophy.